In a filing, TG Therapeutics Inc revealed its Director Lonial Sagar unloaded Company’s shares for reported $0.28 million on Jun 20 ’24. In the deal valued at $16.87 per share,16,348 shares were sold. As a result of this transaction, Lonial Sagar now holds 105,195 shares worth roughly $2.24 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Lonial Sagar sold 9,585 shares, generating $157,098 in total proceeds. Upon selling the shares at $16.39, the Director now owns 99,293 shares.
Before that, Lonial Sagar sold 5,000 shares. TG Therapeutics Inc shares valued at $79,675 were divested by the Director at a price of $15.94 per share. As a result of the transaction, Lonial Sagar now holds 108,878 shares, worth roughly $2.32 million.
Goldman upgraded its TG Therapeutics Inc [TGTX] rating to a Neutral from a a Sell in a research note published on August 02, 2023; the price target was decreased to $12 from $16. BofA Securities began covering TGTX with “an Underperform” recommendation on May 20, 2022. B. Riley Securities maintained its rating on February 23, 2022. It rated TGTX as “a Buy”.
Price Performance Review of TGTX
On Monday, TG Therapeutics Inc [NASDAQ:TGTX] saw its stock fall -4.14% to $21.31. Over the last five days, the stock has lost -8.89%. TG Therapeutics Inc shares have risen nearly 24.77% since the year began. Nevertheless, the stocks have risen 169.75% over the past one year. While a 52-week high of $26.41 was reached on 09/18/24, a 52-week low of $6.46 was recorded on 02/21/24. SMA at 50 days reached $22.46, while 200 days put it at $18.03.
Levels Of Support And Resistance For TGTX Stock
The 24-hour chart illustrates a support level at 20.87, which if violated will result in even more drops to 20.43. On the upside, there is a resistance level at 22.04. A further resistance level may holdings at 22.77. The Relative Strength Index (RSI) on the 14-day chart is 36.50, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.42, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.14%. Stochastics %K at 6.37% indicates the stock is a buying.
How much short interest is there in TG Therapeutics Inc?
A steep rise in short interest was recorded in TG Therapeutics Inc stocks on 2024-09-13, dropping by -2.88 million shares to a total of 29.84 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 32.72 million shares. There was a decline of -9.65%, which implies that there is a negative sentiment for the stock.
